Ohio Physical Therapy Ebook Continuing Education

References Š Adams, M. P., & Holland, L. N. (2011). Pharmacology for nurses: A pathophysiologic approach (3rd ed.). Upper Saddle River, NJ: Pearson/Epocrates. Š Ambizas, E. M., & Etzel, J. V. (2017). Proton pump inhibitors: Considerations with long-term use. U.S. Pharmacists, 42, 4-7. Š Ament, P. W., DiCola, D. B., & James, M. E. (2012). Reducing adverse effects of proton pump inhibitors. American Family Physician, 86, 66-70. Š American Association of Retired Persons Research (AARP). (2016). 2015 Survey on Prescription Drugs. Retrieved from https://www.aarp.org/content/dam/aarp/research/surveys_statistics/health/2015/prescription-drug-report-2015.pdf . Š American Cancer Society (ACS). (2012). Cancer Facts & Figures for Hispanics/Latinos 2012-2014. Retrieved from http:// www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-034778.pdf Š American Cancer Society (ACS). (2013a). Cancer Facts & Figures for African Americans 2013-2014. Retrieved from http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036921.pdf Š American Cancer Society (ACS). (2013b). Cancer Facts & Figures for 2013. Retrieved from http://www.cancer.org/acs/ groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf Š American Cancer Society (ACS). (2016). ACS Guidelines for Nutrition and Physical Activity. Retrieved from https://www. cancer.org/healthy/eat-healthy-get-active/acs-guidelines-nutrition-physical-activity-cancer-prevention/guidelines.html Š American Cancer Society (ACS). (2017). Cancer Facts & Figures for 2017. Retrieved from https://www.cancer.org/ content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and- figures-2017.pdf Š American Physical Therapy Association (APTA). (2014). Guide to Physical Therapist Practice (3rd ed.). Retrieved from http://guidetoptpractice.apta.org/ Š Bartholow, M. (2010). Top 200 prescription drugs of 2009. Pharmacy Times. Retrieved from http://www. pharmacytimes.com/issue/pharmacy/2010/May2010/RxFocusTopDrugs-0510 Š Belko, J., Urueta, G., & Emre, U. (1995). Amoxicillin overdose manifested by hematuria and acute renal failure. Pediatric Infectious Disease Journal, 14 (10), 917-919. Š Boissonnault, W. G. (1999). Prevalence of comorbid conditions, surgeries and medicine use in a physical therapy outpatient population: A multicentered study. Journal of Orthopaedic & Sports Physical Therapy, 29 (9), 506-525. Š Boissonnault, W. G. (2005). Primary care for the physical therapist. St. Louis, MO: Elsevier. Š Boissonnault, W. G., & Di Fabio, R. D. (1996). Pain profile of patients with low back pain referred to physical therapy. Journal of Orthopaedic & Sports Physical Therapy, 24 (4), 180-191. Š Boissonnault, W. G., & Meek, P. D. (2002). Risk factors for anti-inflammatory drug or aspirin-induced gastrointestinal complications in individuals receiving outpatient physical therapy services. Journal of Orthopaedic & Sports Physical Therapy, 32 (10), 510-517. Š Boissonnault, W. G., & Umphred, D. A. (2013). Differential diagnosis Phase 1: Medical screening by the therapist. In D. A. Umphred (Ed.), Neurological rehabilitation (6th ed., pp. 163-178). St. Louis, MO: Mosby. Š Burcusa, S., & Iacono, W. (2007). Risk for recurrence in depression. Clinical Psychology Review, 27 (8), 959-985. Š Byers, T., Nestle, M., McTiernan, A., Doyle, C., Currie-Williams, A., Gansler, T., & Thun, M. (2002). American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA: A Cancer Journal for Clinicians, 52 (2), 92-119. Š Cerhan, J. R., Potter, J. D., Gilmore, J. M., Janney, C. A., Kushi, L. H., Lazoviche, D., et. al. (2004). Adherence to the AICR Cancer Prevention Recommendations and subsequent Morbidity and Mortality in the Iowa Women’s Health Study Cohort. Cancer Epidemiology, Biomarkers & Prevention, 13, 1114-1120. Š Christensen, S., Riis, A., Nørgaard, M., Thomsen, R., & Sorensen, H. (2007). Introduction of newer selective cyclo- oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer. Alimentary Pharmacology & Therapeutics, 25 (8), 907-912. Š Clarke, N. W., Hart, C. A., & Brown, M. D. (2009). Molecular mechanisms of metastasis in prostate cancer. Asian Journal of Andrology, 11 (1), 57-67. Š Deyo, R. A., & Diehl, A. K. (1988). Cancer as a cause of back pain: Frequency, clinical presentation, and diagnostic strategies. Journal of General Internal Medicine, 3 (3), 230-238. Š Di Stasi, S. L., MacLeod, T. D., Winters, G. K., & Binder-Macleod, S. (2010). Effects of statins on skeletal muscle: A perspective for physical therapists. Physical Therapy, 90 (10), 1530-1542. Š Doolittle, N. D. (2004). State of the science in brain tumor classification. Seminar in Oncology Nursing, 20 (4), 224-230. Š Esnaola, N. F., & Ford, M. E. (2012). Racial differences and disparities in cancer care and outcomes. Surgical Oncology Clinics of North America, 21, 417-437. doi:10.1016/j.soc.2012.03.012 Š Fernberg, P., Odenbro, A., Bellocco, R., Boffetta, P., Pawitan, Y., Zendehdel, K., & Adami, J. (2007). Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: A nationwide cohort study in Sweden. Cancer Research, 67 (12), 5983-5986. Š Finger, E. C., & Giaccia, A. J. (2010). Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer and Metastasis Reviews, 29 (2), 285-293. Š Freedberg, D. E., Kim, L. S., & Yang, Y. (2017). The risks and benefits of long-term use of proton pump inhibitors: Expert review and best practice advice from the American Gastroenterological Association. Gastroenterology, 152, 706-715. Š Friedenreich, C. M., & Cust, A. E. (2008). Physical activity and breast cancer risk: Impact of timing, type and dose of activity and population subgroup effects. British Journal of Sports Medicine, 42 (8), 636-647. Š Galenkamp, H., Deeg, D. J., Huisman, M., Hervonen, A., Braam, A. W., & Jylha, M. (2013). Is self-rate health still sensitive for changes in disease and functioning among nonagenarians? Journal of Gerontology, Series B, Psychological Sciences and Social Sciences, 68, 848-858. Š Gallagher, R. (2010). Killing the symptom without killing the patient. Canadian Family Physician, 56 (6), 544-546. Š Garrow, D., & Delegge, M. H. (2010). Risk factors for gastrointestinal ulcer disease in the US population. Digestive Diseases and Sciences, 55 (1), 66-72. Š Goodman, C. C., Heich, J., & Lazaro, R. T. (2018). Differential diagnosis in physical therapy (6th ed.). Philadelphia, PA: W. B. Saunders. Š Gupta, S. C., Kim, J. H., Prasad, S., & Aggarwal, B. (2010). Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer and Metastasis Reviews, 29 (3), 405-434. Š Haggman, S., Maher, C. G., & Refshauge M. (2004). Screening for symptoms of depression by physical therapists managing low back pain. Physical Therapy, 84 (12), 1157-1166. Š Harriss, D. J., Atkinson, G., Batterham, A., George, K., Cable, T., Reilly, T., … Renehan, A. G. (2009). Lifestyle factors and colorectal cancer risk (2): A systematic review and meta-analysis of associations with leisure-time physical activity. Colorectal Disease, 11 (7), 689-704. Š Harvard Health Letter. (2009). Do PPIs Have Long-term Side Effects? Harvard Health Publishing. https://www.health. harvard.edu/staying-healthy/do-ppis-have-long-term-side-effects Š Henschke, N., Maher, C. G., Refshauge, K. M., Herbert, R., Cumming, R., Bleasel, J., … McAuley, J. (2009). Prevalence of and screening for serious spinal pathology in patients presenting to primary care settings with acute low back pain. Arthritis and Rheumatism, 60 (10), 3072-3080. Š Hermann, P. C., Huber, S. L., Herrier, T., Aicher, A., Ellwart, J., Guba, M., … Heeschen, C. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1 (3), 313-323. doi.org/10.1016/j.stem.2007.06.002 Š Holmes, L. Jr., Escalante, C., Garrison, O., Foldi, B., Ogungbade, G., Eissen, E., & Ward, D. (2008). Testicular cancer incidence trends in the USA (1975-2004): Plateau or shifting racial paradigm? Public Health, 122 (9), 862-872. Š Jemal, A., Siegal, R., Xu, J., & Ward, E. (2010). Cancer statistics, 2010. CA: A Cancer Journal for Clinicians, 60 (5), 277-300. Š Kane, S. P. (2017). ClinCalc DrugStats Database, Version 17.0. ClinCalc: http://clincalc.com/DrugStats . Updated 2017. Š Linabery, A. M., & Ross, J. A. (2008). Trends in childhood cancer incidence in the U.S. Cancer, 112 (2), 416-432. Š Logothetis, C. J., & Lin, S. (2005). Osteoblasts in prostate cancer metastasis to bone. Nature Reviews, 5 (1), 21-28. Š Maher, R. L., Hanlon, J. T., & Hajjar, E. R. (2014). Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety, 13 (1), 10.1517/14740338.2013.827660. doi.org/10.1517/14740338.2013.827660 Š Masnoon, N., Shakib, S., Kalish-Ellett, L., & Caughey, G. E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics, 17, 230-240. Š Mayo Clinic. (2017). Pneumonia. Retrieved from https://www.mayoclinic.org/diseases-conditions/pneumonia/ symptoms-causes/syc-20354204?p=1

Š McCullough, M. L., Patel, A. V., Kushi, L. H., Patel, R., Willett, W. C., Doyle, C.,… Gapstur, S. (2011). Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease and all-cause mortality. Cancer Epidemiology Biomarkers & Prevention, 20, 1089-1097. doi:10.1158/1055-9965.EPI-10-1173. Š Minn, A. J., Kang, Y., Serganova, I., Gupta, G., Giri, D., Doubrovin, M., … Massague, J. (2005). Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. Journal of Clinical Investigation, 115 (1), 44-55. Š National Cancer Institute (NCI). (2017a). Examples of Cancer Health Disparities. Retrieved from https://www.cancer. gov/about-nci/organization/crchd/about-health-disparities/examples Š National Cancer Institute (NCI). (2017b) Metastatic Cancer. Retrieved from https://www.cancer.gov/types/metastatic- cancer#where-cancer-spreads Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2014). Citalopram. Retrieved from https://medlineplus.gov/druginfo/meds/a699001.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2015a). Atorvastatin. Retrieved from https://medlineplus.gov/druginfo/meds/a600045.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2015b). Fluticasone. Retrieved from https://medlineplus.gov/druginfo/meds/a601056.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2015c). Losartan. Retrieved from https:// medlineplus.gov/druginfo/meds/a695008.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2016a). Albuterol. Retrieved from https:// medlineplus.gov/druginfo/meds/a607004.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2016b). Rosuvastatin. Retrieved from https://medlineplus.gov/druginfo/meds/a603033.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017a). Acetaminophen . Retrieved from https://medlineplus.gov/druginfo/meds/a681004.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017b). Amlodipine . Retrieved from https://medlineplus.gov/druginfo/meds/a692044.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017c). Amoxicillin . Retrieved from https://medlineplus.gov/druginfo/meds/a685024.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017d). Atenolol . Retrieved from https:// medlineplus.gov/druginfo/meds/a684031.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017e). Azithromycin . Retrieved from https://medlineplus.gov/druginfo/meds/a697037.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017f). Furosemide . Retrieved from https://medlineplus.gov/druginfo/meds/a682858.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017g). Gabapentin . Retrieved from https://medlineplus.gov/druginfo/meds/a694007.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017h). Hydrochlorothiazide . Retrieved from https://medlineplus.gov/druginfo/meds/a682571.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017i). Hydrocodone . Retrieved from https://medlineplus.gov/druginfo/meds/a601006.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017j). Insulin. Retrieved from https://medlineplus.gov/druginfo/meds/a615014.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017k). Levothyroxine . Retrieved from https://medlineplus.gov/druginfo/meds/a682461.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017l). Lisinopril . Retrieved from https://medlineplus.gov/druginfo/meds/a692051.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017m). Metformin . Retrieved from https://medlineplus.gov/druginfo/meds/a696005.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017n). Metoprolol . Retrieved from https://medlineplus.gov/druginfo/meds/a682864.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017o). Omeprazole . Retrieved from https://medlineplus.gov/druginfo/meds/a693050.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017p). Sertraline . Retrieved from https://medlineplus.gov/druginfo/meds/a697048.html Š National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. (2017q). Simvastatin . Retrieved from https://medlineplus.gov/druginfo/meds/a692030.html Š Norman, D. C. (2000). Fever in the elderly. Clinical Infectious Diseases, 31, 148-151. Š Office of Minority Health (OMH), United States Department of Health & Human Services. (2017). Cancer and African Americans. Retrieved from https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=16 Š O’Keefe, E. B., Meltzer, J. P., & Bethea, T. N. (2015). Health disparities and cancer: Racial disparities in cancer mortality in the United States, 2000-2010. Frontiers in Public Health, 3, 1-15. Š Patel, A. V., Rodriguez, C., Pavluck, A. L., Thun, M., & Calle, E. (2006). Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women. American Journal of Epidemiology, 163 (8), 709-716. Š Pedersen, B. K., & Saltin, B. (2006). Evidence for prescribing exercise as therapy in chronic disease. Scandinavian Journal of Medicine & Science in Sports, 16 (S1), 3-63. Š Rahme, E., Bardou, M., Dasgupta, K., Toubouti, Y., Ghosn, J., & Barkun, A. (2007). Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: A retrospective cohort study. Rheumatology, 46 (2), 265-272. Š Rahme, E., Barkun, A. N., Toubouti, Y., Scalera, A., Rochon, S., & Lelorier, J. (2007). Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib? Arthritis & Rheumatism (Arthritis Care & Research), 57 (5), 748-755. Š Romaguera, D., Vergnaud, A. C., Peeters, P. H., van Gils, C. H., Chan, D. S., Ferrari, P., … Norat, T. (2012). Is concordance with World Cancer Research Fund/American Institute for Cancer Research Guidelines for Cancer Prevention related to subsequent risk of cancer? Results from the EPIC study. American Journal of Clinical Nutrition, 96, 150-163. Š Ross, M. D., & Boissonnault, W. G. (2010). Red flags: To screen or not to screen? Journal of Orthopaedic & Sports Physical Therapy, 40 (11), 682-684. Š Schnittker, J., & Bacak, V. (2014). The increasing predictive validity of self-rated health. PLoS ONE, 9 (1), e84933. doi.org/10.1371/journal.pone.0084933 Š Sizer Jr, PS, Brismee, JM and Cook, C. (2007). Medical Screening for Red Flags in the Diagnosis and Management of Musculoskeletal Spine Pain. Pain Practice, 7 (1), 53-71. Š Slipman, C. W., Patel, R. K., Botwin, K., Huston, C., Zhang, L., Lenrow, D., & Garvan, C. (2003). Epidemiology of spine tumors presenting to musculoskeletal physiatrists. Archives of Physical Medicine and Rehabilitation, 84 (4), 492-495. Š Tappenden, P., Jones, R., Paisley, S., & Carroll, C. (2007). Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. Health Technology Assessment, 11 (12), 1-146. Š Thompson, M. P., & Morris, L. K. (1991). Unexplained weight loss in the ambulatory elderly. Journal of the American Geriatrics Society, 39 (5), 497-500. Š Thomson, C. A., McCullough, M. L., Wertheim, B. C., Chlebowski, R. T., Martinez, M. E., Stefanick, M. L.,… Neuhouser, M. L. (2014). Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women’s health initiative. Cancer Prevention Research, 7, 42-53. Š Viswanath, K., Herbst, R. S., Land, S. R., Leischow, S., Shields, P., & Writing Committee for the AACR Task Force on Tobacco and Cancer. (2010). Tobacco and cancer: An American Association for Cancer Research policy statement. Cancer Research, 70 (9), 3419-3430. Š Wang, R., Chen, L., Fan, L., Gao, D., Liang, Z., He, J., … Gao, L. (2015). Incidence and effects of polypharmacy on clinical outcomes among patients aged 80+: A five-year follow-up study. PLoS ONE, 10, e0142123. doi: 10.1371/journal.pone 0142123. Š Ward, E., Jemal, A., Cokkinides, V., Singh, G., Cardinez, C. Ghafoor, A., & Thun, M. (2004). Cancer disparities by race/ethnicity and socioeconomic status. CA: A Cancer Journal for Clinicians, 54 (2), 78-93.

SCREENING FOR MEDICAL CONDITIONS AND ADVERSE DRUG REACTIONS Final Examination Questions Select the best answer for each question and mark your answers on the Final Examination Answer Sheet found on page 116, or complete your test online at EliteLearning.com/Book 53. The goal of Phase 1 of the differential diagnostic process is to determine: a. A specific medical diagnosis for the patient’s condition. b. Which additional tests are needed for a medical diagnosis. c. A specific physical therapy diagnosis for the patient’s condition. d. Whether the condition warrants referral to another healthcare practitioner. 54. According to the classic 1999 Boissonnault study, the comorbid conditions with the highest lifetime prevalence seen in patients receiving outpatient physical therapy services were hypertension and: a. Headaches. b. Cancer. c. Asthma. d. Ulcers.

Page 103

Book Code: PTOH1324

EliteLearning.com/Physical-Therapy

Powered by